Financial statements Nanokosmed
Balance sheet data of NANOKOSMED
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 485 357,69 | 34 238,81 | 28 026,83 | 29 128,29 |
| A. Fixed assets | 17 000,00 | 17 000,00 | 17 000,00 | 17 000,00 |
| B. Current assets | 468 357,69 | 17 238,81 | 11 026,83 | 12 128,29 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 485 357,69 | 34 238,81 | 28 026,83 | 29 128,29 |
| A. Equity | 232 540,60 | 7 902,02 | 2 891,76 | 3 993,22 |
| B. Liabilities and provisions for liabilities | 252 817,09 | 26 336,79 | 25 135,07 | 25 135,07 |
| I. Long-term liabilities | - | - | - | - |
| II. Short-term liabilities | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.